Critical Outcome Technologies, Inc. (COT) Starts Presentation at Annual Marcum MicroCap Conference

Critical Outcome Technologies, Inc. (NYSE: COT) is a leading‐edge technology company focused on accelerating the discovery and development of small molecules to significantly reduce the time and cost to bring new drugs to market. The company’s proprietary artificial intelligence system, CHEMSAS®, utilizes a series of predictive computer models to identify compounds with a high probability of being successfully developed through chemical optimization and preclinical testing. For more information, visit the company’s website at www.criticaloutcome.com